newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors

- Industry veteran brings extensive senior level leadership and expertise in biologics development, strategic partnerships, mergers and acquisitions across biotech and large pharma organizations- Operating experience to